FK228 Enhances Adenoviral Transgene Expression
Author Information
Author(s): Danielsson Angelika, Dzojic Helena, Rashkova Victoria, Cheng Wing-Shing, Essand Magnus
Primary Institution: Uppsala University
Hypothesis
The HDAC inhibitor FK228 enhances adenoviral transgene expression through a transduction-independent mechanism.
Conclusion
FK228 significantly enhances adenoviral transgene expression when administered after transduction, but it does not increase adenovirus replication.
Supporting Evidence
- FK228 increased CD40L expression from 0.3% to 62% in TRAMP-C2 cells.
- Transgene expression was highest when FK228 was added after transduction.
- FK228 did not significantly upregulate CAR or other receptors needed for adenoviral infection.
Takeaway
FK228 is a drug that helps a virus deliver its genes better into cancer cells, but it doesn't make the virus multiply more.
Methodology
The study involved treating various cancer cell lines with FK228 and assessing transgene expression and cell viability through flow cytometry and MTS assays.
Potential Biases
Potential bias in the selection of cell lines and experimental conditions.
Limitations
The study primarily focused on in vitro models, which may not fully represent in vivo conditions.
Participant Demographics
Five healthy volunteers provided blood samples for PBMC isolation.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website